Zydus Lifesciences receives USFDA approval to produce prostrate …
WEB2 days ago · Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to produce a generic prostate cancer treatment drug. The company has received tentative approval from the US Food and Drug Administration (USFDA) to manufacture Enzalutamide tablets (40 mg and 80 mg), the drug maker said in a …
Zydus receives USFDA approval for ZITUVIO™ to treat adult …
WEBOct 20, 2023 · ZITUVIO™ contains active ingredient Sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 ...
Zydus receives USFDA approval for ZITUVIO™ to treat adult …
WEBOct 20, 2023 · Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as 'Zydus') today announced that the U.S. Food and Drug Administration (FDA) approved its New Drug ...
Zydus Life shares in focus today after US FDA approves cancer …
WEB4 days ago · Zydus Life shares gain 1% today after US FDA approves cancer drug worth $870 million. Zydus Lifesciences has received a significant approval from the US FDA for Enzalutamide capsules, which are ...
India's Zydus Lifesciences Q1 profit beats estimates on strong US ...
WEBAug 9, 2024 · Indian drugmaker Zydus Lifesciences reported a bigger-than-expected first-quarter profit on Friday, driven by strong demand for its generic respiratory drugs in its key market of North America.
WEBZydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) today announced that the U.S. Food and Drug Administration (FDA) approved its New Drug Application (NDA) for ZITUVIOTM (Sitagliptin) tablets, 25 …
Zydus Lifesciences gets USFDA nod for Ahmedabad facility
WEB3 days ago · The US health regulator inspected Zydus Lifesciences’ transdermal patch manufacturing facility in Pharmez, Ahmedabad, between July 15 and July 19, the company stated in an exchange filing. The USFDA has now issued an EIR for the facility, classifying it as ‘Voluntary Action Indicated’ (VAI). Shares of Zydus Lifesciences Ltd gained nearly ...
Zydus Lifesciences Gets U.S. FDA Nod To Produce Generic …
WEB6 days ago · Zydus Lifesciences Ltd. on Saturday said it has received approval from the U.S. health regulator to produce generic prostate cancer treatment drug.The company has received approval from the U.S. Food and Drug Administration to manufacture Enzalutamide capsules (40 mg), it said in a regulatory filing.Enzalutamide capsules are androgen receptor inhibitors indicated for the treatment of patients ...
Zydus Receives Tentative Approval from USFDA for Enzalutamide …
WEB2 days ago · Zydus Lifesciences Limited has received tentative approval from the United States Food and Drug Administration to manufacture Enzalutamide Tablets, 40 mg and 80 mg . ... Latest news about Zydus Lifesciences Limited . Zydus Lifesciences Gets Tentative Nod from US FDA for Enzalutamide Tablets 03:26am: MT ...
Zydus Group Latest Update, News And Press Releases - Zydus Life
WEB08 October 2021. Zydus Cadila receives tentative approval from USFDA for Adapalene and Benzoyl Peroxide Gel. 08 October 2021. View More. Get all the latest Zydus Group information, News, Videos, Press Releases and updates here.